Large-scale cell line profiling of drugs provides dose-response curves that contain numerous lesser-considered parameters. Understanding the reasons for systematic variation in these parameters offers new ways to compare drugs and potentially to guide improved drug profiles.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Fallahi-Sichani, M., Honarnejad, S., Heiser, L.M., Gray, J.W. & Sorger, P.K. Nat. Chem. Biol. 9, 708–714 (2013).
Monks, A. et al. J. Natl. Cancer Inst. 83, 757–766 (1991).
Scherf, U. et al. Nat. Genet. 24, 236–244 (2000).
Covell, D.G. PLoS ONE 7, e44631 (2012).
Barretina, J. et al. Nature 483, 603–607 (2012).
Basu, A. et al. Cell 154, 1151–1161 (2013).
Sampah, M.E.S., Shen, L., Jilek, B.L. & Siliciano, R.F. Proc. Natl. Acad. Sci. USA 108, 7613–7618 (2011).
Shi, J., Orth, J.D. & Mitchison, T. Cancer Res. 68, 3269–3276 (2008).
Rabow, A.A., Shoemaker, R.H., Sausville, E.A. & Covell, D.G. J. Med. Chem. 45, 818–840 (2002).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Jenkins, J. Rethinking cellular drug response. Nat Chem Biol 9, 669–670 (2013). https://doi.org/10.1038/nchembio.1365
Published:
Issue Date:
DOI: https://doi.org/10.1038/nchembio.1365